The North America radiofrequency ablation devices market is anticipated to reach US$ 3,214.24 Mn by 2027 from US$ 1,347.06 Mn in 2019. The market is projected to grow at a CAGR of 11.8% from 2020 to 2027.
North America Radiofrequency Ablation Devices Market The radiofrequency ablation devices transmit the energy of radiofrequency waves and destroy the target tissue. North America Radiofrequency Ablation Devices Market This technology has been widely in use to treat solid tumors, arrhythmias, uterine fibroids, and other medical conditions. The growth of the market in North America is driven by factors such as the increasing incidence of chronic illness and growing preference for minimally invasive proceduresin the region. However, side-effects associated with radiofrequency ablation restrain the market growth to a certain extent.
North America Radiofrequency Ablation Devices Market Growing healthcare expenditure is another factor contributing to growth of the North America radiofrequency ablation device market. The rise in the number of patients getting admitted to hospitals to cure suffering from different types of pain, highinsurance premium policies,and high deductibles in hospitals are among the factors responsible for the surge in healthcare costs. North America Radiofrequency Ablation Devices Market According to a study by the American Medical Association, in 2017,the US spent ~US$3.5 trillion on healthcare.Moreover, as per a study published in the Journal of the American Medical Association (JAMA) in March 2019, healthcare expenditure in the US during 1996–2015 rose nearly by US$ 1 trillion. The study reported that the overall healthcare spending in the US was US$3.5 trillion, i.e., ~US$11,000 per person,in 2017, and these costs are expected to climb to US$6 trillion—i.e., ~US$17,000 per person.Further, the increase in the incidence of chronic conditions has had a direct impact on increases in the cost of medical care, and almost half of the Americans have some form of chronic illness.
📚𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 @ https://www.businessmarketinsights.com/reports/north-america-radiofrequency-ablation-devices-market
North America Radiofrequency Ablation Devices Market The RFA treatment is a prime trend in pain management nowadays, and in treatment of chronic illness associated with advancement in technology and healthcare infrastructure facilities is anticipated to havea positive influence in the revenue generation from radiofrequency ablation devices. Minimally invasive treatment procedures are associated with smaller incisions, less pain, shorter hospital stay, faster recovery, North America Radiofrequency Ablation Devices Market less scarring, and increased accuracy, which is leading to a greater preference for these procedures around the world. Moreover, due to lowered pain and discomfort, patients undergoing minimally invasive surgeries do not require large doses of painkillers. Such procedures have small size of the incision, which helps in healing faster than conventional surgeries, thereby allowing patients to get back to their normal lives as quickly as possible.Ablation is one of the most frequently used minimallyinvasive techniques for the treatment of various tumors, AF, and uterine fibroids.According to the American Society for Aestethic Plastic Surgery,the number of minimally invasive cosmetic procedures in the US increased from ~13.9 million in 2014 to 14.2 million in 2015.
North America Radiofrequency Ablation Devices Market The radiofrequency ablation procedure involves the injection of local anesthesia, followed by the insertion of a thin needle through a tiny incision to pass heat and electrical energy. North America Radiofrequency Ablation Devices Market The technology avoids scars and other risks associated with traditional open surgeries. Moreover, as the procedure is devoid of large cuts, it can be carried on extremely sick or old patients, as they cannot bear the stress associated with open surgeries. The completion of the total procedure takes 30–90 minutes, and the patients are monitored for a day, or in several cases, they are discharged on the same day. Further, they can recover in less time and can get back to daily life in ~1–3 weeks. Thus, the benefits associated with the minimal invasiveness of theprocedure of radiofrequency ablation treatment are driving the growth of the market.
North America Radiofrequency Ablation Devices Market North America is witnessing the rapidly growing number of COVID-19 cases; for instance, in the US, the number of cases has been increased to 614,246, with 26,064 deaths reported. According to the Breastcancer.org, in the country, many doctors, hospitals, and other healthcare facilities are delaying or canceling the breast cancer procedures and surgeries, as well as screenings or other treatments if they are not considered urgent, emergencies, or otherwise indicated for life-threatening conditions. Thus, the prevailing COVID-19 pandemic is likely to affect the radiofrequency ablation devices market growing in the coming months.
📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/TIPRE00010856
𝐓𝐡𝐞 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬
Avanos Medical, Inc.
Stryker
Abbott
Boston Scientific
Bard (BD)
Angiodynamic
Hologic
Articure
Merit medical
Radiofrequency Ablation in the Treatment of Chronic Illnesses
RFA is increasingly being used as a treatment option for a variety of medical conditions. The procedure is particularly effective in treating tumors, atrial fibrillation (AF), uterine fibroids, and other conditions that require targeted tissue destruction. RFA is particularly beneficial for treating cancerous tumors, especially those located in hard-to-reach areas, as it offers a less invasive alternative to traditional surgery. RFA has become one of the most common minimally invasive techniques in the treatment of oncological conditions, as it can precisely target and destroy cancer cells with minimal damage to surrounding healthy tissue.
Additionally, atrial fibrillation (AF), a condition characterized by irregular heart rhythms, can be effectively treated with RFA by ablating the heart tissue responsible for the abnormal rhythm. In cases of uterine fibroids, RFA is used to shrink the fibroids, reducing symptoms like heavy bleeding and pelvic pain. The versatility of RFA in treating various chronic conditions, combined with its minimally invasive nature, makes it a highly sought-after treatment option in modern healthcare.
Furthermore, the growing number of minimally invasive cosmetic procedures is further fueling the demand for radiofrequency ablation devices. According to the American Society for Aesthetic Plastic Surgery, the number of minimally invasive cosmetic procedures in the United States increased from approximately 13.9 million in 2014 to 14.2 million in 2015. This growth reflects a broader trend towards non-surgical procedures, which RFA fits into perfectly due to its ability to treat both medical and aesthetic conditions without requiring large incisions or lengthy recovery times.
Radiofrequency Ablation Procedure: How It Works
The radiofrequency ablation process is relatively straightforward but requires precision. After the injection of local anesthesia, a thin needle or catheter is inserted through a small incision. This needle or catheter is then used to transmit heat energy to the target tissue. The heat generated by the radiofrequency energy destroys the abnormal tissue or disrupts the electrical signals causing irregular heart rhythms in the case of atrial fibrillation.
The procedure usually takes between 30 to 90 minutes to complete, depending on the complexity and size of the target area. In many cases, patients can be monitored for a short period after the procedure and, in some instances, can be discharged on the same day. Since the procedure is minimally invasive, it carries fewer risks and offers a quicker recovery time, allowing patients to resume normal activities within one to three weeks after the procedure.
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
You can see this-
North America Menstrual Cups Market- https://www.openpr.com/news/3928669/north-america-menstrual-cups-market-key-players-size-trends
North America Colorectal Cancer Market- https://www.openpr.com/news/3928724/north-america-colorectal-cancer-market-global-trends-share
North America Outdoor Power Equipment Market- https://www.openpr.com/news/3928883/north-america-outdoor-power-equipment-market-key-details
